SCOPE PLANNING COMMITTEE MEMBERS REPRESENT RESEARCH AND CLINICAL PRACTICE WITHIN UNIVERSITIES, HOSPITALS, CORPORATIONS, FOUNDATIONS, AND FEDERAL AGENCIES.
The Planning Committee of the Spinal Cord Outcomes Partnership Endeavor (SCOPE) is a group of experienced individuals, representing a variety of constituencies within spinal cord medicine.
SCOPE leaders:
Jane Hsieh, MSc, Co-Chair
Wings for Life
After receiving graduate neurophysiology training at McGill University, Jane has spent more than 30 years in spinal cord injury (SCI) research. Throughout her career, Jane has been involved with SCI research in academia, industry, non-profit organizations and in my own consulting business. Currently, Jane’s main focus is acting as the Executive Director of the Accelerated Translational Program of Wings for Life. Managing this portfolio requires up to date knowledge of SCI clinical trials from both scientific and operational perspectives. Overseeing two large multi-centre drug trials in chronic SCI and many smaller complex multi-centre trials in acute, chronic, drug, device, and biologic therapeutics has afforded Jane extensive experience in all aspects and types of clinical trials.
Linda Jones, PT, PhD, Co-Chair
Thomas Jefferson University/Christopher & Dana Reeve Foundation
With more than 25 years in spinal cord injury research, Linda is an Associate Professor at Thomas Jefferson University and a consultant to biotechnology companies, universities, and non-profits, to advance spinal cord injury research. After focusing on physical therapy interventions in the intensive care unit, she managed the first cell-based trial in spinal cord injury followed by the first study utilizing cells derived from human embryonic stem cells in the United States. She subsequently joined the Craig H. Neilsen Foundation, managing the translational research portfolio. She is a former Chair of the Research Committee of the American Spinal Injury Association and serves on the National Institute of Neurological Disorders and Stroke, clinical and pre-clinical Common Data Elements for Spinal Cord Injury Committee. Her interests lie in clinical trial design, outcome measures and bridging gaps between pre-clinical and clinical research to promote better alignment between animal and human research.
SCOPE Members:
Linda Bambrick, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Andrew R. Blight, PhD
Acorda Therapeutics, Inc.
Brian Culley
Lineage
Armin Curt, MD, FRCPC
Spinal Cord Injury Center | University of Zurich
Marc DePaul, PhD
NervGen Pharma
Adele Doperalski, PhD
NINDS
Elizabeth Eberhardt
NervGen Pharma
Vieri Faili, PhD
Wings for Life
Michael G. Fehlings MD PhD FRCSC FACS FRSC FCAHS
UHN/University of Toronto
Adam Ferguson, PhD
University of California, San Francisco
Edelle Field-Fote, PT, PhD, FAPTA
Shepherd Center, Atlanta
Dan Graves, PhD
Thomas Jefferson Hospital
James Guest, MD, PhD, FACS
The Miami Project to Cure Paralysis | University of Miami Miller School of Medicine
James Hamer, BA
DP Clinical
Ioana Hone
Lineage Cell Therapeutics
Catherine Jutzeler, Dr
ETH Zürich
Genki Kaneko
Mitsubishi Tanabe Pharma
Steven Kirshblum, MD
Kessler Institute for Rehabilitation
Naomi Kleitman, PhD
Craig H. Neilsen Foundation
John Kramer, PhD
ICORD
Audrey Kusiak, PhD
Department of Veterans Affairs Office of Research and Development
Daniel P. Lammerstse, MD
Craig Hospital
Michael Lauw
Lineage Cell Therapeutics
Verena May, PhD
Wings for Life
Dan Mikol, MD, PhD
NervGen Pharma
Mary Jane Mulcahey, PhD, OTR/L
Jefferson School of Health Professions | Thomas Jefferson University
Kent New, MD, PhD
Ascension St. Vincent’s Neurosurgery
Nancy Nicholas
SCI Community Liaison
Kim Pfleeger
AbbVie
Devinder Poonian
DP Clinical
Beatrice Sandner, PhD
Wings for Life
John Steeves, PhD
University of British Columbia and Vancouver Coastal Health | Vancouver General Hospital
Keith Tansey, MD, PhD
University of Mississippi Medical Center | Spinal Cord Injury Clinic at the Jackson VA Medical Center
Norbert Weidner, Prof. Dr. med.
Heidelberg University Hospital
Tracey Wheeler, PhD
Craig Neilsen Foundation
Konstantin Zubovskiy
Mitsubishi Tanabe Pharma